Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The quality of 5-aminolevulinic acid-induced photodynamic diagnosis and transurethral resection of bladder tumors: does the urologist play a role?.

Draga RO, Grimbergen MC, Kok ET, Jonges TN, van Swol CF, Bosch RJ.

Urol Int. 2012;89(3):326-31. doi: 10.1159/000341897. Epub 2012 Sep 13.

2.

Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.

Ahmad S, Aboumarzouk O, Somani B, Nabi G, Kata SG.

BJU Int. 2012 Dec;110(11 Pt B):E596-600. doi: 10.1111/j.1464-410X.2012.11326.x. Epub 2012 Jul 3.

4.

Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy.

Grimbergen MC, van Swol CF, Jonges TG, Boon TA, van Moorselaar RJ.

Eur Urol. 2003 Jul;44(1):51-6.

PMID:
12814675
5.

Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics.

Kruck S, Bedke J, Hennenlotter J, Amend B, Merseburger A, Stenzl A, Sievert KD.

Urol Int. 2011;87(2):138-42. doi: 10.1159/000328218. Epub 2011 Aug 23.

PMID:
21860210
6.

Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?

Gravas S, Efstathiou K, Zachos I, Melekos MD, Tzortzis V.

Can J Urol. 2012 Jun;19(3):6269-73.

PMID:
22704312
7.

Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics.

Draga RO, Grimbergen MC, Kok ET, Jonges TN, Bosch JL.

Urology. 2009 Oct;74(4):851-6. doi: 10.1016/j.urology.2009.04.095. Epub 2009 Aug 15.

PMID:
19683800
8.

[Value of the photodynamic method in the diagnosis of superficial bladder tumors].

Lipiński MI, Jeromin LM.

Wiad Lek. 2004;57 Suppl 1:192-5. Polish.

PMID:
15884237
9.

Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.

Inoue K, Fukuhara H, Shimamoto T, Kamada M, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Tanimura M, Watanabe H, Shuin T.

Cancer. 2012 Feb 15;118(4):1062-74. doi: 10.1002/cncr.26378. Epub 2011 Jul 19.

10.

Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.

Hermann GG, Mogensen K, Toft BG, Glenthøj A, Pedersen HM.

Scand J Urol Nephrol. 2012 Feb;46(1):31-6. doi: 10.3109/00365599.2011.637954. Epub 2011 Dec 12.

PMID:
22150596
11.

Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.

Kriegmair M, Zaak D, Rothenberger KH, Rassweiler J, Jocham D, Eisenberger F, Tauber R, Stenzl A, Hofstetter A.

J Urol. 2002 Aug;168(2):475-8.

PMID:
12131291
12.
13.

The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder Cancer.

Fukuhara H, Kureishi M, Khoda T, Inoue K, Tanaka T, Iketani K, Orita M, Inoue K, Shuin T.

PLoS One. 2015 Sep 2;10(9):e0136416. doi: 10.1371/journal.pone.0136416. eCollection 2015.

14.
15.

Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.

Neuzillet Y, Methorst C, Schneider M, Lebret T, Rouanne M, Radulescu C, Molinie V, Dreyfus JF, Pelcat V, Botto H.

Urol Oncol. 2014 Nov;32(8):1135-40. doi: 10.1016/j.urolonc.2014.04.005. Epub 2014 Jul 9.

PMID:
25023786
16.

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.

Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, Muschter R, Popken G, König F, Knüchel R, Kurth KH.

J Urol. 2005 Sep;174(3):862-6; discussion 866.

PMID:
16093971
17.

Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.

Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):193-200. doi: 10.1016/j.pdpdt.2015.03.008. Epub 2015 Apr 2.

PMID:
25843912
18.

[Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].

Babjuk M, Soukup V, Petrík R, Pavlík I, Jirsa M, Dvorácek J, Pecen L.

Cas Lek Cesk. 2005;144 Suppl 2:15-8. Czech.

PMID:
16277179
19.

[The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].

Daniltchenko D, Riedl C, Koenig F, Daha LK, Sachs M, Schnorr D.

Aktuelle Urol. 2004 Nov;35(6):497-501. German.

PMID:
15526230
20.

Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D.

J Urol. 2005 Dec;174(6):2129-33, discussion 2133.

PMID:
16280742
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk